Early greetings from the home office, where the power is out and downed trees are blocking my path to WiFi-enabled caffeine parlors. That means I have about one hour of phone hotspot/laptop battery, so we're gonna have to skip the news blurbs this morning. Apologies. Here we go...
FanDuel in talks to go public
FanDuel is in advanced talks to go public, but not via an IPO.
Instead, multiple sources tell Axios that the fantasy sports site is likely to participate in a reverse merger with Platinum Eagle Acquisition Corp., a special purpose acquisition company formed earlier this year by veteran media executive Jeff Sagansky.
- Huh? Special purpose acquisition companies, or SPACs, are basically management teams that raise money from the public markets, with the promise of then buying one or more companies.
- Platinum Eagle raised $300 million earlier this year and currently trades on the NASDAQ.
It's unclear how much Platinum Eagle is paying for the company, or for what percentage. FanDuel last year claimed its fully-diluted value was $1.2 billion, which was calculated for the purpose of a merger with rival DraftKings that was later scuttled by antitrust regulators.
The New York-based company had subsequently held unsuccessful talks with private investors about a new round of funding, on top of the $435 million or so that it already has raised from firms like KKR, NBC Sports, Comcast Ventures and the NBA.
- One source says to think about the Platinum Eagle deal more as a fundraise for FanDuel than as an exit for FanDuel investors.
A company spokeswoman declined comment.
Cigna buying Express Scripts for $54 billion
Health insurer Cigna (NYSE: CI) has agreed to buy pharmacy benefit giant Express Scripts for $52 billion in cash and stock, or $96.03 per share (30% premium to yesterday's closing price). The total deal is valued at $67 billion, inclusive of $15 billion in assumed debt.
- Why it matters: Because horizontal healthcare mergers are coming at a breakneck pace, in what Axios' Bob Herman calls an "all-out turf war." It also likely means that a speculated tie-up between Cigna and Humana is off the table for now.
- Bottom line: This looks a bit like the CVS/Aetna deal, albeit in reverse, but it's really the outgrowth of Anthem breaking with Express Scripts last year after Anthem accused Express Scripts of overcharging by billions of dollars.
The next act for Travis Kalanick
Former Uber CEO Travis Kalanick has launched an investment fund called 10100, which will invest his personal money in both for-profit and non-profit endeavors. Per his announcement:
There also were two new developments from Kalanick's former shop:
Buyout purchase price multiples hit a record high in 2017, according to a new report from Bain & Co.
Icahn slams steel speculation
Carl Icahn yesterday denied that he knew about President Trump's steel tariff plan before it was formally disclosed.
Why it matters: Icahn sold at least part of his stake in The Manitowoc Co., which relies heavily on steel, ahead of Trump's announcement last Thursday. The stock has since fallen more than 5%, but Icahn — who once served as an unpaid economic advisor to Trump — had declined to comment until now:
What we still don't know: If Icahn has sold more Manitowoc shares since his initial disclosure, and what those "legitimate investment reasons" were.
Compranos, por favor
Yesterday we noted that Spanish-language broadcaster Univision had scrapped its IPO plans, and now sources tell us that the company is expected to seek an acquirer.
"There are bankers climbing all over them," says one private equity backer.
- The WSJ reported last night that Univision's board was seeking to replace CEO Randy Falco.
- Chairman Haim Saban then emailed a rebuttal, claiming that Falco had told the board he wants to retire at the end of 2018, and is involved in the transition process.
Thought bubble from Axios' Sara Fischer: Univision will face a challenge trying to find a buyer that's willing to pay more than the $13 billion-plus Discovery reportedly offered last year.